| Jessica Marie Griffith, MD | |
|
5 Mobile Infirmary Circle, Mobile, AL 36607-3513 | |
| (251) 460-0326 | |
| (251) 460-2846 |
| Full Name | Jessica Marie Griffith |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 12 Years |
| Location | 5 Mobile Infirmary Circle, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922364215 | NPI | - | NPPES |
| 282871 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 33057 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Thomas Hospital | Fairhope, AL | Hospital |
| South Baldwin Regional Medical Center | Foley, AL | Hospital |
| North Baldwin Infirmary | Bay minette, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gulf Regional Pathologists Pa | 9830115385 | 7 |
News Archive
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
Women who have a high cardiovascular fitness in middle age have a risk of developing dementia when older that is almost 90 percent lower than among women in average physical condition, according to a study published in the journal Neurology.
In response to rising national health care costs, the Indiana University School of Medicine and Indiana Clinical and Translational Sciences Institute have launched a new center to increase efficacy and reduce costs at four major health care providers across Indiana.
Eli Lilly and Company and ImClone Systems Incorporated have announced the successful completion of the previously announced tender offer by Lilly's wholly-owned subsidiary, Alaska Acquisition Corporation, for all outstanding shares of ImClone at a price of $70.00 per share in cash.
New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.
› Verified 8 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
Women who have a high cardiovascular fitness in middle age have a risk of developing dementia when older that is almost 90 percent lower than among women in average physical condition, according to a study published in the journal Neurology.
In response to rising national health care costs, the Indiana University School of Medicine and Indiana Clinical and Translational Sciences Institute have launched a new center to increase efficacy and reduce costs at four major health care providers across Indiana.
Eli Lilly and Company and ImClone Systems Incorporated have announced the successful completion of the previously announced tender offer by Lilly's wholly-owned subsidiary, Alaska Acquisition Corporation, for all outstanding shares of ImClone at a price of $70.00 per share in cash.
New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.
› Verified 8 days ago
| Entity Name | Gastro Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114039872 PECOS PAC ID: 4981687712 Enrollment ID: O20040611000282 |
News Archive
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
Women who have a high cardiovascular fitness in middle age have a risk of developing dementia when older that is almost 90 percent lower than among women in average physical condition, according to a study published in the journal Neurology.
In response to rising national health care costs, the Indiana University School of Medicine and Indiana Clinical and Translational Sciences Institute have launched a new center to increase efficacy and reduce costs at four major health care providers across Indiana.
Eli Lilly and Company and ImClone Systems Incorporated have announced the successful completion of the previously announced tender offer by Lilly's wholly-owned subsidiary, Alaska Acquisition Corporation, for all outstanding shares of ImClone at a price of $70.00 per share in cash.
New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.
› Verified 8 days ago
| Entity Name | Gulf Regional Pathologists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588776108 PECOS PAC ID: 9830115385 Enrollment ID: O20051024000504 |
News Archive
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
Women who have a high cardiovascular fitness in middle age have a risk of developing dementia when older that is almost 90 percent lower than among women in average physical condition, according to a study published in the journal Neurology.
In response to rising national health care costs, the Indiana University School of Medicine and Indiana Clinical and Translational Sciences Institute have launched a new center to increase efficacy and reduce costs at four major health care providers across Indiana.
Eli Lilly and Company and ImClone Systems Incorporated have announced the successful completion of the previously announced tender offer by Lilly's wholly-owned subsidiary, Alaska Acquisition Corporation, for all outstanding shares of ImClone at a price of $70.00 per share in cash.
New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.
› Verified 8 days ago
| Entity Name | Cunningham Pathology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831195437 PECOS PAC ID: 2668468802 Enrollment ID: O20080218000071 |
News Archive
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
Women who have a high cardiovascular fitness in middle age have a risk of developing dementia when older that is almost 90 percent lower than among women in average physical condition, according to a study published in the journal Neurology.
In response to rising national health care costs, the Indiana University School of Medicine and Indiana Clinical and Translational Sciences Institute have launched a new center to increase efficacy and reduce costs at four major health care providers across Indiana.
Eli Lilly and Company and ImClone Systems Incorporated have announced the successful completion of the previously announced tender offer by Lilly's wholly-owned subsidiary, Alaska Acquisition Corporation, for all outstanding shares of ImClone at a price of $70.00 per share in cash.
New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Marie Griffith, MD Po Box 91498, Mobile, AL 36691-1498 Ph: (251) 460-0326 | Jessica Marie Griffith, MD 5 Mobile Infirmary Circle, Mobile, AL 36607-3513 Ph: (251) 460-0326 |
News Archive
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
Women who have a high cardiovascular fitness in middle age have a risk of developing dementia when older that is almost 90 percent lower than among women in average physical condition, according to a study published in the journal Neurology.
In response to rising national health care costs, the Indiana University School of Medicine and Indiana Clinical and Translational Sciences Institute have launched a new center to increase efficacy and reduce costs at four major health care providers across Indiana.
Eli Lilly and Company and ImClone Systems Incorporated have announced the successful completion of the previously announced tender offer by Lilly's wholly-owned subsidiary, Alaska Acquisition Corporation, for all outstanding shares of ImClone at a price of $70.00 per share in cash.
New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.
› Verified 8 days ago
Dr. Lloyd Gardner, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-460-0326 Fax: 251-460-2846 | |
Dr. Lee Fucich, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-460-0326 Fax: 251-460-2846 | |
Elizabeth A. Manci, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1700 Center St, Pathology, Mobile, AL 36604 Phone: 251-415-1612 Fax: 251-415-1003 | |
Carole Boudreaux, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2451 Fillingim St, Pathology, Mobile, AL 36617 Phone: 251-471-7790 Fax: 251-471-7715 | |
Jonathan Newsom, Pathology Medicare: Medicare Enrolled Practice Location: 2451 University Hospital Dr, Mobile, AL 36617 Phone: 251-470-9912 | |
Dr. Rodney Edwin Shackelford, DO Pathology Medicare: Medicare Enrolled Practice Location: 2451 University Hospital Dr, Mobile, AL 36617 Phone: 251-471-7790 Fax: 251-471-7096 | |
Eugene Hart, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2451 Fillingim St, Department Of Pathology, Mobile, AL 36617 Phone: 251-471-7026 |